Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma

Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma

Background: Lung adenocarcinoma (LUAD) possesses a poor prognosis with a low 5-year survival rate even for stages I-III resected patients, it is thus critical to understand the determinants that affect the survival and discover new potentially prognostic biomarkers. Somatic copy number alterations (...

Full description

Bibliographic Details
Main Authors: Xiaohong Han, Qiaoyun Tan, Sheng Yang, Junling Li, Jianping Xu, Xuezhi Hao, Xingsheng Hu, Puyuan Xing, Yutao Liu, Lin Lin, Lin Gui, Yan Qin, Jianliang Yang, Peng Liu, Xingyuan Wang, Wumin Dai, Dongmei Lin, Hua Lin, Yuankai Shi
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-08-01
Series:Frontiers in Oncology
Subjects:
lung adenocarcinoma
copy number alteration
prognosis
predict
adjuvant chemotherapy
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00556/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00556/full

Similar Items